Contents

Current Cancer Therapy Reviews, Volume 6 - Number 1

IP6 in Cancer Therapy: Past, Present and Future

, 6(1): 1 - 12

Agata Matejuk and Abulkalam Shamsuddin


DOI: 10.2174/157339410790596443




Clinical Update: Treatment of Glioblastoma Multiforme with Radiolabeled Antibodies that Target Tumor Necrosis

, 6(1): 13 - 18

Randy L. Jensen, Joseph S. Shan, Bruce D. Freimark, Debra A. Harris, Steven W. King, Jennifer Lai and Missag H. Parseghian


DOI: 10.2174/157339410790596489




Liver-Directed Regional Therapy in the Multi-Disciplinary Management of Hepatocellular Cancer

, 6(1): 19 - 25

Maheswari Senthil, Brian Mailey, Lucille Leong, Vincent Chung, Yun Yen, Yi-Jen Chen, Howard Marx and Joseph Kim


DOI: 10.2174/157339410790596461




Physiological and Molecular Role of Ranpirnase on Cancer Treatment

, 6(1): 26 - 33

Intae Lee, Daehong Kim, Jihean Lee and Kuslima Shogen


DOI: 10.2174/157339410790596425




Regulatory T Cells and Cancer Therapy: An Old Story with a New Hope

, 6(1): 34 - 40

Xinhai Zhang, Rick F. Thorne, Thomas E. Wagner and Yanzhang Wei


DOI: 10.2174/157339410790596470




MicroRNA-21 as a Novel Therapeutic Target

, 6(1): 41 - 50

Mohit Sachdeva, Shoumin Zhu and Yin-Yuan Mo


DOI: 10.2174/157339410790596452




Endocrine Therapy for Advanced Breast Cancer: Beyond Tamoxifen and Aromatase Inhibitors

, 6(1): 51 - 61

Angel Guerrero-Zotano and Franco Muggia


DOI: 10.2174/157339410790596498




The Potency of Refined Mouse Models: Implications for Clinical Trials

, 6(1): 62 - 80

Ralph Graeser, Ulrike Fiedler, Norbert Esser, Andrea Klotzbuecher, Holger Weber and Christoph Schaechtele


DOI: 10.2174/157339410790596434




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science